D.H. Lee
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Lung Cancer Research Studies
-
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Oncology 11
- Lung Cancer Research Studies 6
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 2
-
- Lung Cancer Treatments and Mutations 7
- Lung Cancer Diagnosis and Treatment 2
- Co-authors
- Jane Healy (3 shared papers)Jiaxin Niu (3 shared papers)Kathryn F. Mileham (3 shared papers)Hyun Cheol Chung (3 shared papers)Elliot Chartash (3 shared papers)Corinne Maurice‐Dror (3 shared papers)Talia Golan (2 shared papers)Ulka N. Vaishampayan (2 shared papers)
- Journals
- Annals of Oncology (11 papers)Journal of Thoracic Oncology (3 papers)Pediatric Pulmonology (1 paper)American Journal of Neuroradiology (1 paper)
- Partner nations
- South KoreaUnited StatesSwitzerland
In The Last Decade
D.H. Lee
15 papers receiving 397 citations
D.H. Lee's Hit Papers
Peers
Comparison fields: 5 of 51
- Oncology 240
- Immunology 137
- Pulmonary and Respiratory Medicine 75
- Neurology 28
- Otorhinolaryngology 5
Countries citing papers authored by D.H. Lee
This map shows the geographic impact of D.H. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.H. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.H. Lee more than expected).
Fields of papers citing papers by D.H. Lee
This network shows the impact of papers produced by D.H. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.H. Lee. The network helps show where D.H. Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside D.H. Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer☆ Hit paper breakdown → | 2021 | 207 |
| 2 | 2007 | 53 | |
| 3 | 2007 | 43 | |
| 4 | 2009 | 36 | |
| 5 | 2020 | 26 | |
| 6 | 2020 | 19 | |
| 7 | 2012 | 4 | |
| 8 | 2021 | 3 | |
| 9 | 2023 | 2 | |
| 10 | 2021 | 2 | |
| 11 | 2024 | 1 | |
| 12 | 2014 | 1 | |
| 13 | 2022 | 1 | |
| 14 | 2022 | 1 | |
| 15 | 2019 | 1 | |
| 16 | 2012 | 0 |
About D.H. Lee
D.H. Lee is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Molecular Biology and Cancer Research, having authored 16 papers that have together received 400 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Neuroendocrine Tumor Research Advances (4 papers), Cancer Genomics and Diagnostics (2 papers), Cancer therapeutics and mechanisms (2 papers), CAR-T cell therapy research (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (240 citations), Immunology (137 citations), Pulmonary and Respiratory Medicine (75 citations), Neurology (28 citations) and Otorhinolaryngology (5 citations). D.H. Lee has collaborated with scholars based in South Korea, United States and Switzerland. Frequent co-authors include Jane Healy, Jiaxin Niu, Kathryn F. Mileham, Hyun Cheol Chung, Elliot Chartash, Corinne Maurice‐Dror, Talia Golan, Ulka N. Vaishampayan, Drew Rasco and Mark Voskoboynik. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Pediatric Pulmonology and American Journal of Neuroradiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.